Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Cell|October 21, 2004
Retroviral pseudotransduction for targeted cell manipulationMelanie Galla, Elke Will, Janine Kraunus, et al.
The Journal of Biological Chemistry|November 7, 2002
Posttranslational modification of serine to formylglycine in bacterial sulfatases. Recognition of the modification motif by the iron-sulfur protein AtsBClaudia Marquordt, Qinghua Fang, Elke Will, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 18, 2005
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cellsAxel Schambach, Jens Bohne, Saurabh Chandra, et al.
Nucleic Acids Research|June 13, 2002
Unmodified Cre recombinase crosses the membraneElke Will, Hannes Klump, Nicole Heffner, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2005
HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cuesElke Will, Daniel Speidel, Zheng Wang, et al.
Blood|October 31, 2002
High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiationBernhard Schiedlmeier, Hannes Klump, Elke Will, et al.
Experimental Hematology|May 2, 2006
Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical researchAxel Schambach, Melanie Galla, Ute Modlich, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2005
HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cellsSandra Pilat, Sebastian Carotta, Bernhard Schiedlmeier, et al.
Experimental Hematology|December 10, 2003
Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector doseZhixiong Li, Maike Schwieger, Claudia Lange, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2007
Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trialsElke Will, Jeff Bailey, Todd Schuesler, et al.
Pageof 1